Medication for Opioid Use Disorder: A National Survey of Primary Care Physicians.
作者信息
McGinty Emma E, Stone Elizabeth M, Kennedy-Hendricks Alene, Bachhuber Marcus A, Barry Colleen L
机构信息
Johns Hopkins Bloomberg School of Public Health and Johns Hopkins Center for Mental Health and Addiction Policy Research, Baltimore, Maryland (E.E.M., E.M.S., A.K., C.L.B.).
Section of Community and Population Medicine, Louisiana State University Health Sciences Center-New Orleans, New Orleans, Louisiana (M.A.B.).
出版信息
Ann Intern Med. 2020 Jul 21;173(2):160-162. doi: 10.7326/M19-3975. Epub 2020 Apr 21.
Abstract
摘要
相似文献
1
Medication for Opioid Use Disorder: A National Survey of Primary Care Physicians.阿片类物质使用障碍的药物治疗：一项针对基层医疗医生的全国性调查。
Ann Intern Med. 2020 Jul 21;173(2):160-162. doi: 10.7326/M19-3975. Epub 2020 Apr 21.
2
Comparing Buprenorphine-Prescribing Physicians Across Nonmetropolitan and Metropolitan Areas in the United States.比较美国非大都市和大都市地区的丁丙诺啡处方医生。
Ann Fam Med. 2019 May;17(3):212-220. doi: 10.1370/afm.2384.
3
Opioid therapy for chronic pain: physicians' attitude and current practice patterns.慢性疼痛的阿片类药物治疗：医生的态度及当前实践模式
J Opioid Manag. 2011 Jul-Aug;7(4):267-76. doi: 10.5055/jom.2011.0068.
4
Barriers and facilitators for emergency department initiation of buprenorphine: A physician survey.急诊科启动丁丙诺啡治疗的障碍与促进因素：一项医生调查。
Am J Emerg Med. 2019 Sep;37(9):1787-1790. doi: 10.1016/j.ajem.2019.02.025. Epub 2019 Feb 18.
5
Comparison of Opioid Prescribing Patterns in the United States and Japan: Primary Care Physicians' Attitudes and Perceptions.美国和日本阿片类药物处方模式的比较：初级保健医生的态度和认知
J Am Board Fam Med. 2017 Mar-Apr;30(2):248-254. doi: 10.3122/jabfm.2017.02.160299.
6
Opioids and chronic pain in primary care.基层医疗中的阿片类药物与慢性疼痛
Br J Gen Pract. 2018 Oct;68(675):454-455. doi: 10.3399/bjgp18X698921.
7
Prescribing Practices of Rural Physicians Waivered to Prescribe Buprenorphine.农村医生开具丁丙诺啡处方的规定豁免。
Am J Prev Med. 2018 Jun;54(6 Suppl 3):S208-S214. doi: 10.1016/j.amepre.2018.02.006.
8
Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians.克服开具丁丙诺啡用于治疗阿片类药物使用障碍的障碍：农村医生的建议。
J Rural Health. 2019 Jan;35(1):113-121. doi: 10.1111/jrh.12328. Epub 2018 Oct 19.
9
Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania.宾夕法尼亚州基于证据的护理多模式实施治疗阿片类药物使用障碍。
J Subst Abuse Treat. 2019 Nov;106:58-64. doi: 10.1016/j.jsat.2019.08.016. Epub 2019 Aug 28.
10
Use of Opioid Agonist Therapy for Medicare Patients in 2013.2013年医疗保险患者使用阿片类激动剂治疗情况
JAMA Psychiatry. 2016 Sep 1;73(9):990-2. doi: 10.1001/jamapsychiatry.2016.1390.
引用本文的文献
1
Using narrative and informational messages to improve correctional professionals' attitudes toward medications for opioid use disorder.运用叙述性和信息性信息来改善惩教专业人员对阿片类药物使用障碍药物治疗的态度。
Health Justice. 2025 Aug 26;13(1):53. doi: 10.1186/s40352-025-00363-3.
2
Palliative care for people with substance use disorders: a qualitative study of the experiences of rural primary care providers.物质使用障碍患者的姑息治疗：对农村初级保健提供者经历的定性研究
BMC Palliat Care. 2025 Jul 23;24(1):210. doi: 10.1186/s12904-025-01828-w.
3
The impact of psychostimulant use on office based buprenorphine treatment retention.使用精神兴奋剂对基于办公室的丁丙诺啡治疗留存率的影响。
Harm Reduct J. 2025 Apr 12;22(1):51. doi: 10.1186/s12954-025-01201-3.
4
Understanding the financial barriers to treatment among individuals with opioid use disorder: a focus group study.了解阿片类物质使用障碍患者治疗的经济障碍：一项焦点小组研究。
Harm Reduct J. 2024 Dec 20;21(1):220. doi: 10.1186/s12954-024-01133-4.
5
Innovations to the ECHO model to enhance reach and network-building among addiction clinicians in Western Canada.对扩展社区医疗成果（ECHO）模式的创新，以提高加拿大西部成瘾临床医生的覆盖面并加强网络建设。
Addict Sci Clin Pract. 2024 Dec 18;19(1):93. doi: 10.1186/s13722-024-00524-z.
6
The Implementation Climate for Integrating Buprenorphine Prescribing into Rural Primary Care.将丁丙诺啡处方纳入农村初级保健的实施环境
J Gen Intern Med. 2024 Dec 12. doi: 10.1007/s11606-024-09260-1.
7
Clinician Prescribing Practices Involving Medications for Alcohol Use Disorder.临床医生针对酒精使用障碍开具药物的处方行为。
Am J Prev Med. 2025 Mar;68(3):446-454. doi: 10.1016/j.amepre.2024.11.006. Epub 2024 Nov 28.
8
Clinician and Practice Characteristics Associated With Support of Office-based Methadone: Findings From a National Survey.与门诊美沙酮支持相关的临床医生和实践特征：一项全国性调查的结果
J Addict Med. 2025;19(2):150-156. doi: 10.1097/ADM.0000000000001388. Epub 2024 Oct 30.
9
Physicians' Self-Reported Knowledge and Behaviors Related to Prescribing Opioids for Chronic Pain and Diagnosing Opioid Use Disorder, DocStyles, 2020.医生自我报告的与慢性疼痛开具阿片类药物及诊断阿片类药物使用障碍相关的知识和行为，DocStyles，2020年
AJPM Focus. 2024 Aug 22;3(6):100269. doi: 10.1016/j.focus.2024.100269. eCollection 2024 Dec.
10
Linkage facilitation for opioid use disorder in criminal legal system contexts: a primer for researchers, clinicians, and legal practitioners.刑事法律系统背景下阿片类物质使用障碍的联动促进：研究人员、临床医生和法律从业者入门指南
Health Justice. 2024 Aug 29;12(1):36. doi: 10.1186/s40352-024-00291-8.
本文引用的文献
1
Buprenorphine Deregulation and Mainstreaming Treatment for Opioid Use Disorder: X the X Waiver.丁丙诺啡管制放松与阿片类物质使用障碍的主流治疗：X豁免权。
JAMA Psychiatry. 2019 Mar 1;76(3):229-230. doi: 10.1001/jamapsychiatry.2018.3685.
2
Methadone in Primary Care - One Small Step for Congress, One Giant Leap for Addiction Treatment.基层医疗中的美沙酮——对国会来说是一小步，对成瘾治疗来说是一大步。
N Engl J Med. 2018 Jul 5;379(1):7-8. doi: 10.1056/NEJMp1803982.
Zotero 插件